Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Health Topics
GeneDx expands exome testing program for pediatric epilepsy patients
By
LabPulse.com staff writers
GeneDx has expanded its patient access program for pediatric epilepsy, which provides access to whole exome sequencing to qualifying pediatric patients.
December 5, 2024
FDA sounds bacteria alarms over CGMP violations in Maine
By
Liz Carey
Tom's troubles highlight the importance of being inspection-ready.
November 21, 2024
Vesalius, GSK announce strategic alliance on neurodegenerative disease treatments
By
LabPulse.com staff writers
Biotech firm Vesalius Therapeutics announced a strategic collaboration with GSK aimed at the discovery and development of therapeutics for Parkinson's disease and another undisclosed neurodegenerative disease.
November 15, 2024
Veravas, Phanes Biotech to collaborate on Alzheimer's tau pathology assay
By
LabPulse.com staff writers
Clinical diagnostics developer Veravas and Phanes Biotech have announced that they will co-develop a blood-based Alzheimer’s disease (AD) tau pathology test.
November 8, 2024
Sunbird Bio shares new data on blood-based Parkinson's diagnostic
By
LabPulse.com staff writers
Biotech firm Sunbird Bio announced new data from a study demonstrating that Sunbird's technology could provide blood-based diagnosis of Parkinson's disease and other neurodegenerative diseases with a high level of accuracy.
November 1, 2024
Alzheimer's panel validated in University of Pittsburgh study
By
LabPulse.com staff writers
A team at the University of Pittsburgh has validated a new blood test panel that can simultaneously measure over 100 Alzheimer's disease biomarkers.
November 4, 2024
Magellan Diagnostics sentenced for concealing lead-testing device malfunction
By
LabPulse.com staff writers
Magellan Diagnostics was sentenced in federal court for criminal charges related to concealing a device malfunction that caused inaccurately low lead test results for tens of thousands of children and other patients.
October 14, 2024
Biomarker, tissue study shows body composition in patients treated with Ozempic
By
Liz Carey
Artificial intelligence tools may aid healthcare teams in monitoring the negative impacts of weight loss and diabetes drugs.
September 20, 2024
Rapid diagnostic test developed for ALS
By
LabPulse.com staff writers
A blood diagnostic test for amyotrophic lateral sclerosis (ALS) has been developed that can rapidly distinguish ALS from conditions that mimic ALS in its early stages with a high level of specificity and sensitivity.
September 13, 2024
C2N, Unilabs sign global agreement on early Alzheimer's diagnostics
By
LabPulse.com staff writers
C2N and Unilabs have signed a multiyear agreement that will increase access to C2N's Precivity blood tests for the early diagnosis of Alzheimer's disease to Unilabs' testing network on an exclusive basis.
August 8, 2024
Diagnostic laboratory joint venture expands RNA sequencing at Baylor
By
LabPulse.com staff writers
WT RNAseq goes beyond the interpretation of already identified variants by whole exome sequencing (WES) or whole genome sequencing (WGS), according to Baylor Genetics.
August 6, 2024
ALZpath, Roche sign licensing agreement for dementia biomarker
By
LabPulse.com staff writers
ALZpath has signed a licensing agreement with Roche for the use of the ALZpath pTau217 antibody to develop and commercialize a diagnostic blood test for Alzheimer's disease that will be offered on the Roche Elecsys platform.
June 12, 2024
Page 1 of 71
Next Page
